Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/09/2022* -- Results Q3 2022 -- -0.26 --
02/09/2022* 10:00 EST Earnings Call Q3 2022 -- -- --
11/05/2021 -- Results Q2 2022 -0.01 -0.15 94.10%
11/05/2021 10:00 EST Earnings Call Q2 2022 -- -- --
08/06/2021 -- Results Q1 2022 0.97 -0.23 520.6%
08/06/2021 10:00 EST Earnings Call Q1 2022 -- -- --
06/01/2021 -- Results Q4 2021 -1.33 -0.19 -586.2%
06/01/2021 10:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 02/09/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/05/2021
Beat/Miss Upgrade
Return Since -38.68%
Last FQE 09/30/2021
Next FQE 12/30/2021

Profile

Edit
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
URL https://www.canopygrowth.com
Investor Relations URL https://www.canopygrowth.com/investors/
HQ State/Province Ontario
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 09, 2022
Last Earnings Release Nov. 05, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
22.56%
217.1%
246.9%
13.58%
-21.51%
16.83%
-64.57%
-17.18%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-8.67%
--
--
--
--
-75.72%
-51.78%
-14.89%
-20.91%
--
--
--
--
--
-84.27%
22.13%
-20.68%
-32.14%
-14.98%
115.7%
50.55%
197.1%
-31.74%
65.37%
-32.44%
-44.04%
-68.72%
-60.09%
-83.95%
-24.91%
3.66%
32.47%
-27.18%
As of January 26, 2022.

Profile

Edit
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
URL https://www.canopygrowth.com
Investor Relations URL https://www.canopygrowth.com/investors/
HQ State/Province Ontario
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 09, 2022
Last Earnings Release Nov. 05, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
CNBS 3.276M CAD 9.68%
AMRHX 54309.00 CAD 4.08%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Stocktwits CGC Tweets